Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer; Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04021108
What this trial is testing

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Who this might be right for
Gastroesophageal Adenocarcinoma
Weill Medical College of Cornell University 80
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Not applicableUnknownNCT06441240
What this trial is testing

Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.

Who this might be right for
Breast CancerChemotherapy EffectTriple Negative Breast Cancer+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 933
Testing effectiveness (Phase 2)Study completedNCT00193050
What this trial is testing

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752550
What this trial is testing

Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Harbin Medical University 120
Early research (Phase 1)Active Not RecruitingNCT04526691
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Who this might be right for
Advanced or Metastatic NSCLC
Daiichi Sankyo 145
Not applicableLooking for participantsNCT04409860
What this trial is testing

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 120
Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Not applicableLooking for participantsNCT05947838
What this trial is testing

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Who this might be right for
Appendiceal AdenocarcinomaColorectal
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Looking for participantsNCT02559778
What this trial is testing

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Who this might be right for
Neuroblastoma
Giselle Sholler 500
Large-scale testing (Phase 3)Study completedNCT01233843
What this trial is testing

Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

Who this might be right for
Squamous Cell Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 370
Large-scale testing (Phase 3)UnknownNCT03779035
What this trial is testing

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Tianjin Medical University Cancer Institute and Hospital 460
Very early researchUnknownNCT04048317
What this trial is testing

Effectiveness of Drug Eluting TACE in Primary HCC

Who this might be right for
Hepatic Cell Carcinoma
Assiut University 75
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Large-scale testing (Phase 3)Looking for participantsNCT06200168
What this trial is testing

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
ElectroacupunctureOlanzapine-contained Four-drug AntiemeticNausea and Vomiting
Jiuda Zhao 370
Early research (Phase 1)Looking for participantsNCT06696768
What this trial is testing

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT01116791
What this trial is testing

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisGastrointestinal Cancer
Baki Topal 34
Testing effectiveness (Phase 2)WithdrawnNCT03187691
What this trial is testing

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Matinas BioPharma Nanotechnologies, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07213674
What this trial is testing

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 750
Not applicableUnknownNCT05059782
What this trial is testing

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Who this might be right for
Ovarian CancerNeoplasm, OvarianOvarian Neoplasm+14 more
Xi'an Jiaotong University 150
Next Page